Gopal Kundu | |
---|---|
Born | Bataspur, West Bengal | 2 November 1959
Nationality | Indian |
Known for | Therapeutics; Biomarker (cell); Angiogenesis; Nanomedicine; |
Awards | N-BIOS Prize, Shanti Swarup Bhatnagar Prize for Science and Technology |
Scientific career | |
Fields | Cancer |
Institutions | National Centre for Cell Science |
Gopal Chandra Kundu (born 1959) is an Indian cell and cancer biologist and a Senior Scientist (Scientist-G) at National Centre for Cell Science.[1] He is known for his contributions towards the understanding the mechanism of cancer progression in breast, melanoma and other cancers and development of novel therapeutic targets and target-based therapy in cancers.[2]
An elected fellow of the Indian Academy of Sciences[3] and the National Academy of Sciences, India,[4] he received the National Bioscience Award for Career Development of the Department of Biotechnology in 2003.[5] The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 2004, for his contributions to biological sciences.[6]